1-9 of 9
Shuyang He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of CD19 CAR Engineered Human Placental CD34 + -Derived Natural Killer Cells (CAR19-CYNK) As an Allogeneic Cancer Immunotherapy

Marina Gergues, Irene Raitman, Joseph Gleason, Valentina Rousseva, Shuyang He, William Van Der Touw, Qian Ye, Lin Kang, Yanliang Zhang, Chin-I Pai, Wenzhong Guo, Henry Ji, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2779.
https://doi.org/10.1182/blood-2021-150593
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) in Combination with Daratumumab for Immunotherapy Against CD38 Expressing Hematological Malignancies

Irene Raitman, Joseph Gleason, Salvatore Rotondo, Shuyang He, Valentina Rousseva, Xuan Guo, Hemlata Rana, William van der Touw, Qian Ye, Lin Kang, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2773.
https://doi.org/10.1182/blood-2021-148869
Published: 2021
Journal Articles

Human Placenta Derived Exosomes Enhance Ischemia Repair in a Mouse Model of Hind-Limb Ischemia

Qian Ye, PhD, Shuyang He, PhD, Joseph Gleason, MS, Bhavani Stout, Navjot Shah, John Hariri, Chole Holland, Srinivas Somanchi, PhD, Xiaokui Zhang, PhD, Robert Hariri, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-137452
Published: 2020
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) for ADCC Mediated Cancer Immunotherapy

Lin Kang, Irene Raitman, PhD, Salvatore Rotondo, MS, Joseph Gleason, MS, Shuyang He, PhD, Srinivas Somanchi, PhD, Valentina Rousseva, MS, Xuan Guo, PhD, Hemlata Rana, MS, Andrea DiFiglia, BS, Qian Ye, PhD, Tanel Mahlakõiv, PhD, William Van Der Touw, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-140536
Published: 2020
Journal Articles

Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Mediate Protection Against Influenza A Viral Infection

Shuyang He, PhD, Tanel Mahlakõiv, PhD, Joseph Gleason, MS, William Van Der Touw, Lin Kang, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-139049
Published: 2020
Journal Articles

Development of CD38 CAR Engineered Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (PNK-CAR38) As Allogeneic Cancer Immunotherapy

Srinivas Somanchi, PhD, Xuan Guo, PhD, Shuyang He, PhD, Rohit Mathur, PhD, Andrea Difiglia, BS, Hemlata Rana, MS, Weifang Ling, PhD, James Edinger, PhD, Gunnar F. Kaufmann, PhD, Jerome B. Zeldis, MD PhD, Henry Ji, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2070.
https://doi.org/10.1182/blood-2019-129539
Published: 2019
Journal Articles

Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell Malignancies

Kathy Karasiewicz, MSc, Shuyang He, PhD, Mary Ng, MSc, Kristina Tess, Weifang Ling, PhD, Gunnar F. Kaufmann, PhD, Jerome B. Zeldis, MD PhD, Henry Ji, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3222.
https://doi.org/10.1182/blood-2019-130782
Published: 2019
Journal Articles

Engineering High Affinity and Cleavage Resistant CD16 to Augment ADCC of Placental Hematopoietic Stem Cells-Derived Natural Killer Cells

Xuan Guo, PhD, Srinivas Somanchi, PhD, Rohit Mathur, PhD, Shuyang He, PhD, Qian Ye, PhD, Andrea Difiglia, BS, Salvatore Rotondo, MS, Hemlata Rana, MS, Weifang Ling, PhD, James Edinger, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1576.
https://doi.org/10.1182/blood-2019-127009
Published: 2019
Journal Articles

Human Placenta-Derived Adherent Cells Delivered Intralesionally Inhibit Myeloma Bone Disease and Tumor Growth, While Intravenously Are Capable of Trafficking to Myelomatous Bone.

Xin Li, PhD, Wen Ling, MS, Angela Pennisi, MD, Yuping Wang, PhD, Sharmin Khan, MS, Mohammad Heidaran, PhD, Ajai Pal, PhD, Xiaokui Zhang, PhD, Shuyang He, PhD, Andy Zeitlin, Stewart Abbot, PhD, Herbert Faleck, DO, Robert Hariri, MD, PhD., John Shaughnessy, Jr., PhD, Frits van Rhee, MD, PhD, Bijay Nair, MD, MPH, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD
Journal: Blood
Blood (2010) 116 (21): 3717.
https://doi.org/10.1182/blood.V116.21.3717.3717
Published: 2010